DocNoc Company

Our AI-led second opinion diagnosis platform will reduce misdiagnosis of breast cancer due to clinical error or false clinical tests.


Investors

Headquarters: London, England, United Kingdom
Total Funding: 1332931
Founded Date: 2015-10-30
Employee Number: 45200
Last Funding Type: Venture - Series Unknown
Technology: HealthCare Administration
Funding Status: Private
Industry: Medical BioTech